Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

news.sanofi.us

Press Room (Corporate News)

Get the latest updates from Press Room (Corporate News) directly as they happen.

Follow now 41 followers

Latest posts

Last updated 21 days ago

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

21 days ago

Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement

24 days ago

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

about 1 month ago

Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

about 1 month ago

Chlamydia vaccine candidate granted fast track designation by the US FDA

about 1 month ago

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis

about 2 months ago

Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

about 2 months ago

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

2 months ago

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid

3 months ago

New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

4 months ago

Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

5 months ago

ASH: SARCLISA® combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients

5 months ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now